コンテンツへスキップ
Merck
  • An integrated in vitro imaging platform for characterizing filarial parasite behavior within a multicellular microenvironment.

An integrated in vitro imaging platform for characterizing filarial parasite behavior within a multicellular microenvironment.

PLoS neglected tropical diseases (2014-11-21)
Timothy Kassis, Henry M Skelton, Iris M Lu, Andrew R Moorhead, J Brandon Dixon
要旨

Lymphatic Filariasis, a Neglected Tropical Disease, is caused by thread-like parasitic worms, including B. malayi, which migrate to the human lymphatic system following transmission. The parasites reside in collecting lymphatic vessels and lymph nodes for years, often resulting in lymphedema, elephantiasis or hydrocele. The mechanisms driving worm migration and retention within the lymphatics are currently unknown. We have developed an integrated in vitro imaging platform capable of quantifying B. malayi migration and behavior in a multicellular microenvironment relevant to the initial site of worm injection by incorporating the worm in a Polydimethylsiloxane (PDMS) microchannel in the presence of human dermal lymphatic endothelial cells (LECs) and human dermal fibroblasts (HDFs). The platform utilizes a motorized controllable microscope with CO2 and temperature regulation to allow for worm tracking experiments with high resolution over large length and time scales. Using post-acquisition algorithms, we quantified four parameters: 1) speed, 2) thrashing intensity, 3) percentage of time spent in a given cell region and 4) persistence ratio. We demonstrated the utility of our system by quantifying these parameters for L3 B. malayi in the presence of LECs and HDFs. Speed and thrashing increased in the presence of both cell types and were altered within minutes upon exposure to the anthelmintic drug, tetramisole. The worms displayed no targeted migration towards either cell type for the time course of this study (3 hours). When cells were not present in the chamber, worm thrashing correlated directly with worm speed. However, this correlation was lost in the presence of cells. The described platform provides the ability to further study B. malayi migration and behavior.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
酢酸, glacial, ACS reagent, ≥99.7%
Sigma-Aldrich
酢酸, glacial, ReagentPlus®, ≥99%
Sigma-Aldrich
酢酸, glacial, ≥99.99% trace metals basis
Sigma-Aldrich
酢酸 溶液, suitable for HPLC
Sigma-Aldrich
酢酸, glacial, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, 99.8-100.5%
Sigma-Aldrich
酢酸, for luminescence, BioUltra, ≥99.5% (GC)
USP
氷酢酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
酢酸, ≥99.5%, FCC, FG
Sigma-Aldrich
酢酸, natural, ≥99.5%, FG
Sigma-Aldrich
5α-アンドロスタン-17β-オール-3-オン, ≥97.5%
Sigma-Aldrich
酢酸, glacial, puriss., 99-100%
Sigma-Aldrich
オクタメチルトリシロキサン, viscosity 1.0 cSt (25 °C)
Sigma-Aldrich
オクタメチルトリシロキサン, 98%
Supelco
酢酸, analytical standard
Sigma-Aldrich
酢酸, JIS special grade, ≥99.7%
Sigma-Aldrich
酢酸, ≥99.7%
Sigma-Aldrich
5α-アンドロスタン-17β-オール-3-オン, purum, ≥99.0% (TLC)
Sigma-Aldrich
酢酸, SAJ first grade, ≥99.0%
Sigma-Aldrich
ポリ(ジメチルシロキサン), viscosity 0.65 cSt (25 °C)
Sigma-Aldrich
酢酸 溶液, 1 M, 1 N
Sigma-Aldrich
ヒドロコルチゾン21-アセタート, ≥98% (HPLC)
Sigma-Aldrich
酢酸, ≥99.7%, SAJ super special grade
Sigma-Aldrich
酢酸, ≥99.7%
USP
ヒドロコルチゾン21-アセタート, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
酢酸, ≥99.7%, for titration in non-aqueous medium
ヒドロコルチゾン21-アセタート, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Acetic acid-12C2, 99.9 atom % 12C
Sigma-Aldrich
ヒドロコルチゾン 酢酸塩, meets USP testing specifications
Sigma-Aldrich
酢酸, 99.5-100.0%
Millipore
Bifido Selective Supplement B, suitable for microbiology